Peugeot Invest exits Groupe SEB with €236 million deal

PARIS, FRANCE: Peugeot Invest has sold its entire stake in Groupe SEB, a French manufacturer of small appliances, for €236 million. The deal was done through a private placement to institutional investors at €106 per share, a financial news announcement noted. Peugeot Invest, an investment company majority-owned by Etablissements Peugeot Frères, had invested in Groupe…

Wilhelmsen New Energy to acquire a 21% stake in Reach Subsea for NOK 150mn

HAUGESUND, NORWAY: Reach Subsea announced that Wilhelmsen New Energy AS has entered into an investment agreement whereby Wilhelmsen has agreed to become a 21% shareholder in Reach Subsea through subscribing for NOK 150 million in a directed private placement. The investment agreement forms part of a broader partnership, which will see the launch of the…

Celyad Oncology sells 28.8% shares to Fortress Group for $32.5mn

BRUSSELS, BELGIUM: Celyad Oncology SA has entered into a subscription agreement with an affiliate of Fortress Investment Group for the private placement of 6.5 million ordinary shares for gross proceeds of USD 32.5 million (about EUR 28.7 million). The subscription will take place within the framework of the authorized capital and it is expected to…

BALYO closes €7.8 million private placement with French & int’l investors

PARIS, FRANCE: BALYO announced the success of a capital increase with cancellation of the preferential subscription right by placement of a final amount of €6.1 million to qualified French and international investors, carried-out by accelerated construction of an order book. Concurrently with the Primary Offer, funds managed by Seventure Partners, historical shareholder of the Company…

Arctic Bioscience plans NOK 250 million private placement, listing on Euronext Growth Oslo

ØRSTA: Arctic Bioscience AS has engaged ABG Sundal Collier ASA and DNB Markets as joint global coordinators and joint bookrunners for a contemplated private placement raising gross proceeds of NOK 250 million and admission to trading of the Company’s shares on Euronext Growth Oslo. Arctic Bioscience is a biotech company founded based on specialised know-how…

Icelandic Salmon engages advisors to effect NOK 579 million private placement

KVERVA: Icelandic Salmon, a subsidiary of SalMar ASA, has engaged DNB Markets, a part of DNB Bank ASA as Sole Global Coordinator and Joint Bookrunner, and Arctic Securities AS and Arion Banki hf. as Joint Bookrunners to advise on and effect a contemplated private placement of up to 5.038 million shares. The Private Placement consists…

Elliptic Laboratories successfully places NOK 125 million private placement

OSLO: Elliptic Laboratories AS has announced a successful private placement raising gross proceeds of NOK 125 million through the allocation of 833,333 new shares at a subscription price of NOK 150 per share. The Private Placement attracted very strong interest from Norwegian, Nordic and international high-quality institutional investors and was significantly oversubscribed. Three cornerstone investors…